Abstract
On day of parturition (day 0), Brown Swiss cows were assigned to either a control untreated group (n=6) or one of two groups (n = 6/group) in which cows were treated twice daily from days 0 to 6 postpartum with Flunixin Meglumine (FM; 1 g/i.m. injection), a prostaglandin synthetase inhibitor. Cows treated with FM received a continuous infusion of either 0.9% saline (FM + saline; days 1 to 10: 46.5 ml/day) or prostaglandin F 2α (PGF 2α) Tham salt (FM + PGF 2α; days 1 to 3 and 7 to 10: 33.8 mg/day; days 4 to 6: 67.7 mg/day) into the descending aorta via a catheter inserted into the costoabdominal artery. Rectal palpation was thrice weekly from days 5 to 60 postpartum to assess utero-ovarian morphological changes. Profile of 15-keto-13, -14-dihydro-PGF 2α (PGFM) concentrations in peripheral plasma collected between days 1 and 11 was lower (p<0.01) in the FM + saline than in the control group animals. IN contrast, following replacement with PGF 2α, profiles of PGFM were similar in the FM + PGF 2α and control groups although peak concentrations were delayed by 2 days in the FM + PGF 2α group. Postpartum decrease in cervical and uterine horn diameter and location of the uterus in the pelvic canal did not differ (P>0.1) among groups. Compared to control cows, ovarian activity of both ovaries was reduced (p<0.01) following partial suppression of prostaglandin synthesis early postpartum. However, replacement with PGF 2α increased (p<0.01) ovarian activity of ovaries ipsilateral to the previously gravid uterine horn. We concluded that partial suppression of prostaglandin synthesis early postpartum did not alter rate of uterine involution in cattle and that PGF 2α may be implicated in the resumption of ovarian activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.